Abstract
The aim of this study was to evaluate the survival of patients with testicular cancer in Lithuania during 1998-2002 and factors that influenced the survival. The survival rates of testicular cancer patients were evaluated using the data of the Lithuanian Cancer Registry for 1998-2002. The survival was evaluated using the Kaplan-Meier method and log-rank test in order to compare the survival rates. The observed survival rates were calculated. The 5-year observed survival rate in Lithuania was 71.2% (95% CI, 64.4%-77.5%). The survival of testicular cancer patients depended on age at the time of diagnosis, histology of tumor, stage and extent of disease. The survival of patients with testicular cancer in Lithuania was substantially lower than in other European countries. The better survival was associated with younger age and lesser extent of metastases.
Highlights
Testicular cancer (TC) is a rare malignant disease
The 5-year observed survival rate in Lithuania was 71.2%
The survival of testicular cancer patients depended on age at the time of diagnosis, histology of tumor, stage and extent of disease
Summary
Testicular cancer (TC) is a rare malignant disease. An average of 49 000 new TC cases are diagnosed worldwide. It constitutes 0.8% of all malignant diseases in men [1, 2]. A dramatic increase in TC morbidity has been reported from many countries. The causes of this trend are not known. The highest mortality rate is observed among men aged 15 to 44 years, and in this age group, TC is the most common malignant disease in the developed countries (constitutes 13.4% of all new cancer cases). Positive outcomes of therapy have been associated with appropriate treatment using modern chemotherapy
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
